Transcatheter Aortic Valve Implantation in Patients With Super Obesity: Defining a High-Risk Phenotype
Super-obese TAVI recipients have higher early risk and persistent excess risk for selected complications, indicating that extreme obesity defines a higher-risk TAVI phenotype despite broadly comparable longer-term outcomes versus patients with lower BMI.
Authors
- Said Ashraf (ORCID: https://orcid.org/0000-0002-3461-9034)
- Sohaib Roomi (ORCID: https://orcid.org/0000-0001-5998-9309)
- Waqas Ullah (ORCID: https://orcid.org/0000-0001-9317-7363)
- M Chadi Alraies
- Yasemin Bahar
- Abdul Rasheed Bahar
Institutions
- Wayne State University (US)
- Thomas Jefferson University Hospital (US)
- Detroit Medical Center (US)
- AtlantiCare (US)
Publication Details
- Journal
- Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1097/hpc.0000000000000410
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00